UNSPSC 51332881: Trifluoperazine maleate

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C21H24F3N3S.2C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AN9ZJ2YUI0, chemically known as phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, maleate (1:2), but more generally known as trifluoperazine maleate, which bears US NIH Compound Identifier 5282418.

European Medicines Agency schedules trifluoperazine maleate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11288MIG. Most nations, for tariff purposes, schedule trifluoperazine maleate under HS 29343090. SMILES: CN1CCN(CC1)CCCN2C3C(CCC(C3)C(F)(F)F)SC4C2CCCC4.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51332881 Trifluoperazine maleate (Commodity) is a specific antipsychotic pharmaceutical with limited recent state and local procurement activity aligned to its narrow scope. The three recent opportunities posted under this code are substantively unrelated to trifluoperazine: one solicits naloxone and drug deactivation systems (a harm-reduction product), another is a market-intelligence RFI on direct-to-manufacturer prescription programs, and the third is a cooperative purchasing vehicle for generic multi-source pharmaceuticals and OTC products broadly. None of these solicitations target trifluoperazine maleate specifically. The code appears inactive for state and local procurement purposes at present, with no concrete demand signals for the pharmaceutical itself.

Given the mismatch between the code's nominal scope and the opportunities tagged to it, this code warrants monitoring rather than active pursuit. The broader pharmaceutical and OTC cooperative purchasing space (exemplified by the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802, due March 26, 2026) may offer entry points for pharmaceutical suppliers with products on approved formularies and manufacturing certifications (cGMP, DSCSA), but trifluoperazine maleate does not appear to be a current procurement priority for state health agencies, county health departments, or cooperative purchasing alliances. Vendors with inventory of this antipsychotic should track cooperative purchasing and state Medicaid pharmacy benefit RFPs for formulary inclusions, but should not expect immediate opportunity under this code.